Vasomotor symptoms in menopause: Where we've been and where we're going

Journal of Women's Health

Volumn 15, Issue 2, 2006, Pages 135-145

  Pinkerton, Joann V ^a   Zion, Adrienne S ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; CLONIDINE; CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN; FLUOXETINE; MEDROXYPROGESTERONE; NORADRENALIN; PAROXETINE; PLACEBO; PRASTERONE; PREGNENOLONE; PROGESTERONE; SEROTONIN; SEROTONIN 2A RECEPTOR; TESTOSTERONE; VENLAFAXINE; YOHIMBINE;

CLIMACTERIUM; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE ORGANIZATION; HEALTH HAZARD; HISTORY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; MOOD DISORDER; NIGHT SWEAT; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SHORT COURSE THERAPY; SLEEP APNEA SYNDROME; SLEEP DISORDER; SYMPTOMATOLOGY; THERMOREGULATION; TIME SERIES ANALYSIS; VASOMOTOR DISORDER; WOMEN'S HEALTH;

AFFECT; ATTITUDE TO HEALTH; CULTURE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HOT FLASHES; HUMANS; MEDICINE IN LITERATURE; MENOPAUSE; MIDDLE AGED; QUALITY OF LIFE; SLEEP; TERMINOLOGY; WOMEN'S HEALTH;

EID: 33645644931     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.15.135     Document Type: Review

References (55)

1. Sowers MF. The menopause transition and the aging process: A population perspective. Aging (Milano) 2000;12:85.
2. Napheys GH. The change of life. In: The physical life of woman: Advice to the maiden, wife and mother. Philadelphia: George Maclean, 1871:292.
3. Graham TJ. Of the final cessation of the menses. In: On the diseases of females: A treatise illustrating their symptoms, causes, varieties, and treatment. London: Simpkin, Marshall & Company, 1837:94.
4. Longshore-Potts AM. Menstrual cessation, or "change of life." In: Discourses to women on medical subjects. London: Self-published, 1887:92-96.
5. Pierce RV. The turn of life (cessation of the menses). In: The people's common sense medical adviser in plain English; or, medicine simplified. Buffalo, NY: World's Dispensary Printing Office and Bindery, 1892:728.
6. Melendy MR. Change of life. In: Perfect womanhood for maidens-wives-mothers. Chicago, IL: Monarch Book Co. 1903:174.
7. Lorand A. Menopause. In: Old age deferred: The causes of old age and its postponement by hygienic and therapeutic measures. 6th ed., translated into English. Philadelphia: F.A. Davis Company, 1928:441.
8. Stopes MC. The "change" in women. In: Enduring passion. London: G.P. Putnam's Sons, 1929:146.
9. Fielding WJ. Casting out fear. In: Sex and the lovelife. New York: Blue Ribbon Books, 1927:202.
10. Scholl BF. Menopause, climacteric, the turn or change of life. Philadelphia: Historical Publishing Co., 1930.
11. Palmer RL, Greenberg SK. The change of life. In: Facts and frauds in women's hygiene: A medical guide against misleading claims and dangerous products. New York: Sun Dial Press, 1936:100.
12. Klinger P. The menopause in women (climacteric). In: Vitasexualis: The truth about human sex life. Warsaw, Poland, 1939.
13. Greenblatt RB. Estrogen therapy for postmenopausal females. N Engl J Med 1965;272:305.
14. Bakke JL. A teaching device to assist active therapeutic intervention in the menopause. West J Surg Obstet Gynecol 1963;71:241.
15. Wilson RA. Menopause - The loss of womanhood and the loss of good health. In: Feminine forever. New York: M. Evans & Co., Inc., 1966:92.
16. Johannes CB, Crawford SL. Menstrual bleeding, hormones, and the menopausal transition. Semin Reprod Endocrinol 1999;17:299.
17. World Health Organization. Research on the menopause in the 1990's. WHO Technical Report Series 866. Geneva, Switzerland: World Health Organization, 1996.
18. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267.
19. Mansfield PK, Carey M, Anderson A, Barsom SH, Koch PB. Staging the menopausal transition: Data from the TREMIN Research Program on Women's Health. Womens Health Issues 2004;14:220.
20. Utian WH. Semantics, menopause-related terminology, and the STRAW reproductive aging staging system. Menopause 2001;8:398.
21. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351.
22. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463.
23. Kronenberg F. Hot flashes: Epidemiology and physiology. Ann NY Acad Sci 1990;592:52.
24. Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes D. Hot flushes. Lancet 2002;360:1851.
25. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: Position statement of The North American Menopause Society. Menopause 2004;11:11.
26. Berendsen HH. The role of serotonin in hot flushes. Maturitas 2000;36:155.
27. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol 1999;180:S312.
28. Moe KE. Hot flashes and sleep in women. Sleep Med Rev 2004;8:487.
29. Saure A, Planellas J, Poulsen HK, Jaszczak P. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women. Maturitas 2000;34:133.
30. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345.
31. Beyene Y. Cultural significance and physiological manifestations of menopause. A biocultural analysis. Cult Med Psychiatry 1986;10:47.
32. Huffmann SB, Myers JE. Counseling women in midlife: An integrative approach to menopause. J Couns Dev 1999;77:258.
33. American Society for Reproductive Medicine. Survey of reproductive health professionals exposes the need for additional education tools on hormone replacement therapy. Birmingham, AL. 2004.
34. Ghali WA, Freund KM, Boss RD, Ryan CA, Moskowitz MA. Menopausal hormone therapy: Physician awareness of patient attitudes. Am J Med 1997;103:3.
35. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25.
36. Utian WH, Janata JW, Kingsberg SA, Schluchter M, Hamilton JC. The Utian Quality of Life (UQOL) Scale: Development and validation of an instrument to quantify quality of life through and beyond menopause. Menopause 2002;9:402.
37. Guidance for Industry. Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms - Recommendations for clinical evaluation. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2003.
38. Deecher DC. Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symptoms. Expert Opin Investig Drugs 2005;14:434.
39. Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995;80:2354.
40. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 1999;181:66.
41. Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998;70:332.
42. 2-adrenergic mechanism in menopausal hot flushes. Obstet Gynecol 1990;76:573.
43. National Institutes of Health. NIH State-of-the-Science Conference Statement on Management of Menopause-Related Symptoms, 2005. NIH Consensus Development Program, March 21-23, 2005.
44. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 2002; 165:1217.
45. Gambacciani M, Ciaponi M, Cappagli B, et al. Effects of low-dose, continuous combined estradiol and norethisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003;44:157.
46. Bobula JD. Vasomotor symptoms and quality of life (QoL) in postmenopausal women. Value Health 2003;6:707.
47. Henderson VW, Klein BEK, Resnick SM. Menopause and disorders of neurologic function, mental health, and the eye. In: Wenger N, ed. International position paper on women's health and menopause: A comprehensive approach. Bethesda, MD: National Institutes of Health, 2002:251.
48. Polo-Kantola P, Erkkola R. Sleep and the menopause. J Br Menopause Soc 2004;10:145.
49. Ockene JK, Barad DH, Cochrane BB, et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005;294:183.
50. Blumel JE, Castelo-Branco C, Binfa L, et al. Quality of life after the menopause: A population study. Maturitas 2000;34:17.
51. Food and Drug Administration. Special report. From test tube to patient: Improving health through human drugs. Washington, DC: FDA Center for Drug Evaluation and Research, September 1999.
52. American College of Obstetricians and Gynecologists. Executive summary. Hormone therapy. Obstet Gynecol 2004;104:1S.
53. North American Menopause Society [serial online]. Bioidentical hormones. 2005. Available at www.menopause.org/consumers/bioidentical.htm Accessed February 14, 2004.
54. Boothby LA, Doering PL, Kipersztok S. Bioidentical hormone therapy: A review. Menopause 2004;11:356.
55. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: A systematic review. Obstet Gynecol 2004; 104:824.